INTRODUCTION
Primary open-angle glaucoma (POAG) is a neurodegenerative disease (1) characterized by loss of retinal ganglion cells, optic nerve degeneration, and as a consequence, visual field loss and eventually blindness. It is recognized as a complex disease estimates of related quantitative traits as optic disc area (ODA), vertical cup -disc ratio (VCDR), IOP and central corneal thickness are high (52 -59%; 48-80%; 35-42% and 68 -72%, respectively (6 -9) ).
Developments in the field of genomics have opened opportunities to uncover the genetic mechanisms involved in POAG. To date, at least 20 genetic loci have been linked to POAG, including three causative genes (MYOC, OPTN, WDR36) (10) (11) (12) . In addition, genome-wide association studies (GWASs) have allowed the identification of candidate genes, such as CAV1/ CAV2 (13, 14) , which are expressed in the trabecular meshwork as well as in retinal ganglion cells, and TMCO1 which is also expressed in retinal ganglion cells (15) .
As in other disorders, GWAS of POAG have targeted on endophenotypes, i.e. heritable quantitative determinants of POAG. This approach has facilitated the identification of genes that were subsequently implicated in POAG. Three of the six loci that have been associated with neurodegeneration of the optic nerve (VCDR) (16) were also associated with POAG (17) . The strongest associations were seen for the single-nucleotide polymorphism (SNP) rs1900004, within 10 kb of the ATOH7 gene; the rs10483727 near SIX1-SIX6 genes and the rs1063192, in the 3 ′ UTR region of CDKN2B gene. Two of these variants point to pathways involved in growth and development of the optic nerve. ATOH7 and SIX1-SIX6 genes are transcription factors involved in eye development (18) (19) (20) (21) (22) . The role of ATOH7 in eye development and retinal ganglion cell differentiation has been well characterized in several animal models (18) (19) (20) . SIX1 and SIX6 are homeoprotein members of the SIX/ sine oculis family of homeobox transcription factors (22) . SIX1 is highly expressed in skeletal muscle (23) and has been involved in myogenesis (24) , while SIX6 is highly expressed in the developing eye (25, 26) . To date, it is not clear which one of the two genes is causally related to optic nerve degeneration and POAG, asking for a more in-depth analysis of the SIX1-SIX6 region.
The protein encoded by CDKN2B gene, the third POAG gene identified by GWAS of VCDR, has emerged as a key protein in the pathogenesis of optic nerve degeneration and POAG in different populations (15) (16) (17) (27) (28) (29) (30) (31) (32) (33) . CDKN2B gene is a member of the family of cyclin-dependent kinase (CDK) inhibitors which play a role in cell cycle regulation, influencing the proliferation/ differentiation balance (34) . In the Six6 null mice it was demonstrated that Six6 repress the transcription of members of the Cdkn1 family, particularly Cdkn1b (35) . Therefore, it may be speculated that the SIX1-SIX6 region is potentially related to the CDKN2B regulation, although this has not been described.
In this study, we investigated the SIX1 -SIX6 locus in depth in human and zebrafish. First, we fine-mapped the region and performed a conditional, and exome sequencing analysis. As we found two variants that pointed to SIX6 as best candidate gene, we next characterized the effect of six6b knockdown on eye development of zebrafish and evaluated expression levels of several target genes in morphants, including cdkn2b.
RESULTS

Fine mapping of the SIX1 -SIX6 region
The results of the analyses in the Rotterdam Study (RS) and the Erasmus Rucphen Family (ERF) study are shown in Table 1 . The
IOP analysis included 5782 (RS-I), 2116 (RS-II), 2038 (RS-III) and 2589 (ERF) participants. The optic nerve head analyses included 5322 (RS-I), 2054 (RS-II), 1966 (RS-III) and 2131
(ERF) participants with reliable data. The case-control studies consisted of 188 cases and 5548 controls from the RS-I and 104 cases and 2126 controls from the GRIP/ERF study.
Fine mapping of the SIX1 -SIX6 region based on imputations of the SNPs using 1000 Genomes Project revealed a missense variant rs33912345 in SIX6, this variant is in complete linkage disequilibrium with the previous reported intergenic variant rs10483727 (the two D' and r 2 ¼ 1). Both the rs10483727 and the missense variant in SIX6 rs33912345 were associated with VCDR (P meta ¼ 5.56 × 10 27 and 7.74 × 10 207 , respectively), ODA (P meta ¼ 1.69 × 10 23 and 3.51 × 10
23
, respectively) and POAG (P meta ¼ 2.95 × 10 23 and 6.09 × 10 23 , respectively) (see Table 1 ). The significant association between rs10483727 and VCDR disappeared after adjustment for rs33912345 (P meta ¼ 8.72 × 10
21
), indicating that the SIX6 variant is most likely responsible for the association. This variant determines an amino acid change (His141Asn) in the homeobox DNAbinding domain of SIX6. PolyPhen-2 (36) predicted a benign effect (score ¼ 0) for this evolutionarily conserved variant, based on the Genomic Evolutionary Rate Profiling (GERP) (37) score ¼ 5.38. No significant association was found with variants in SIX1.
Exome sequencing of SIX1 -SIX6 region
To determine whether there were other unobserved rare variants in SIX6, we explored the presence of exonic variants associated with VCDR in this region. In exome sequence data from 1208 individuals of the ERF study, we found another missense variant, rs146737847 (MAF ¼ 0.0023), in SIX6 (P ¼ 1.25 × 10
23
). This evolutionarily conserved variant (GERP ¼ 5.38) determines an amino acid change (Glu129Lys) in the homeobox DNA-binding domain of SIX6, which PolyPhen-2 predicted as probably damaging (score ¼ 0.971). When conducting a conditional analysis on rs33912345, the rs146737847 variant remained associated with VCDR (P ¼ 4.58 × 10
), confirming that both variants are independent of each other. Direction of the effect of both variants was the same; rs33912345 (b ¼ 0.011, se ¼ 0.002) and rs146737847 (b ¼ 0.183, se ¼ 0.055). No exonic variants in SIX1 were significantly associated with VCDR eQTL and expression analyses No significant cis or trans-eQTLs effects for rs10483727, rs33912345 or rs14673784 were found in the GTEx project database (38) . The Ocular Tissue Database (39) was used to compared the expression levels of SIX1 and SIX6 in different human ocular tissues. We found that SIX6 is highly expressed in relevant tissues for POAG, including cornea, optic nerve, trabecular meshwork and retina, compared with SIX1 (PLIER number 27 Exclusion of an eQTL effect of the evaluated SNPs on the gene expression of SIX1 or SIX6, together with the fine-mapping and exome sequencing data, suggests that the variants in SIX6 rather than SIX1 explain the observed association signal reported in previous studies in the region.
Identification and characterization of zebrafish six6b
A zebrafish six6 ortholog was retrieved from the Ensembl database. Two genes were found, six6a and six6b. The protein encoded by six6a together with the protein encoded by six6b was blasted against the human SIX6 protein, showing that six6a and six6b independently have 91% identity to the human SIX6, while the overall identity of both zebrafish six6 to the human protein is 88% (Supplementary Material, Fig. S1 ). In this study, we evaluated the effect of six6b depletion.
To evaluate the role of six6b at different time points of the development, a quantitative reverse transcription PCR (RT-qPCR) was performed. Taking reference expression levels at 1 day post fertilization, we found that over time expression of six6b gradually increases, reaching a peak at the larvae stage of 3 dpf, then decreasing at 5 dpf (Fig. 3A) .
six6b is required for normal eye development in zebrafish
To evaluate the function of six6b during embryonic development, two non-overlapping antisense MOs were designed, the first one targeting the AUG translation initiation site (six6b AUG-MO) and the other targeting the exon1/intron1 splice site (six6b SB-MO). Since embryos injected with either six6b AUG-MO or six6b SB-MO developed similar dose-dependent (2-12 ng) small eye size compared with controls, the six6b SB-MO (6 ng) was selected for further studies as it provided the possibility of quantifying the efficiency of knockdown by RT-qPCR. Embryos injected with the highest concentration of the MOs (12 ng) showed a severe phenotype (twisted trunk, small head and eye, massive heart edema and lethality at 4 dpf, data not shown). Eye size difference between injected and control embryos was quantified at 5 dpf since the phenotype is then well defined and easy to evaluate (Fig. 1A) . Seventy-eight percent of the injected embryos showed a small eye phenotype (n ¼ 286). RT-qPCR analysis indicated six6b SB-MO reduced six6b mRNA levels by 70% (Supplementary Material, Fig. S2 ). To elucidate whether morphants showed small eye phenotype secondary to six6b knockdown as opposed to an overall delay in development, we measured the ratio of the eye size to body length (E:B) (40) . The E:B ratio was measured in 30 embryos of each group (Fig. 1B) . Morphants showed small eyes compared with controls, suggesting an eye development delay (mean E:B ¼ 0.064 versus 0.092, P ¼ 4.96 × 10
220
). Other abnormalities were observed as pericardial edema, diffuse pigmentation that resembles an expanded melanophore phenotype, small head, and in some embryos short jaw. To exclude the presence of small head as a principal cause of a small eye, we measured the ratio of the eye size to head length (E:H) in 30 embryos of each group (i.e. wild-type (WT), six6b SB-MO injected and six6b SB-MO + p53-MO co injected). This measure provides the possibility of evaluating the impact of six6b knockdown on eye size independent of the head size reduction. The E:H ratio was significantly smaller in morphants compared with WT embryos (mean E:H ¼ 0.445 versus 0.530, P ¼ 2.59 × 10 210 ; Supplementary Material, Fig. S3 ). We performed two control experiments; first, a specific p53-targeting MO (4 ng) was co-injected with the six6b SB-MO (6 ng) to exclude whether the phenotype observed was due to off-target effects mediated by induction of p53 expression. The mean ratio E:B in p53-MO co-injected embryos was 0.061, showing a small eye phenotype comparable with six6b knockdown (P ¼ 2.41 × 10
231
). Excluding a small eye size as a consequence of p53-mediated apoptosis pathway. Second, we conducted rescue experiments using WT six6b mRNA. Since no difference in the body length was observed between WT and morphants at 5 dpf (mean ¼ 3.952 mm versus 3.908 mm, respectively; P ¼ 1.95 × 10 21 ), assessment of rescue experiments was focused on eye dimensions only. Co-injection of six6b SB-MO with wt-six6b mRNA resulted in a partial, but significant, rescue of small eye phenotype (mean eye area improved from 1.425. 
Loss of six6b results in immature and underdeveloped eyes
In order to carry out detailed assessment of the six6b SB-MO small eye phenotype, histological analysis was performed on embryos at 3 and 5 dpf ( Fig. 2A -G ). Histology revealed that retinal lamination in morphants occurred. Therefore, the ganglion cell layer (GCL), inner nuclear layer (INL), and outer nuclear layer (ONL) were visualized by H&E staining. Although the optic nerve was seen leaving the retina, its thickness was decreased compared with WT embryos. A semi-quantitative analysis on serial sections of six microns showed that the optic nerve thickness on WT embryos (n ¼ 4) was around 21 mm, while in morphants (n ¼ 4) it was 12 mm. In addition, the lens of 3 dpf morphants was immature and cellularized compared with controls of the same age, supporting that eyes of morphants were delayed in development. Eyes of morphants at 5 dpf showed a conserved general architecture, leaving small size as the principal difference between control embryos and morphants at this age. Immunohistochemical localization of six6 was studied using a rabbit anti-SIX6 polyclonal antibody on sections at 3 and 5 dpf ( Fig. 2B-H ). Since the rabbit anti-SIX6 can recognize the protein products of the closely related six3a and six3b as well, the anti-SIX6 immunoreactivity was only used to investigate the localization of six6/3 proteins in the zebrafish retina, not for the efficiency of six6b knockdown. Both WT and morphants were analyzed. Consistent with previous studies in chick embryos, mouse, and human fetal and adult eye (21, 22, (41) (42) (43) , we found six6/3 protein localized in the nuclei of the GCL, the nuclei of potential bipolar, amacrine and horizontal cells located in the INL, the nuclei of the photoreceptors and the optic nerve (Fig. 2B-F) . In general, labeling in WT embryos at 3 dpf was stronger than at 5 dpf. Morphants at 3 dpf presented less intense labeling, as predicted from expression data.
Expression patterns of six3a and six3b in six6b morphants
The SIX gene family of homeoproteins is required in both Drosophila and vertebrates for eye development. Similar to SIX6, SIX3 has also been involved in eye development (26, (44) (45) (46) , both genes share high homology and are expressed during early stages (21, 25) . To determine whether zebrafish six3 can compensate six6b depletion, RT-qPCR of morphants at 3 dpf was performed. Two orthologs of the human SIX3 were retrieved from Ensembl, six3a (ENSDARG00000058008) and six3b (ENSDARG0000 0054879). RT-qPCR of morphants compared with WT showed an expected down-regulation of six6b. Surprisingly, we found down-regulation of six3a in morphants as well, while expression levels of six3b were not significantly deregulated (Fig. 3B) .
Knockdown of six6b up-regulate expression of the cell cycle inhibitor cdkn2b in zebrafish
Since Six6/Dach interacts with some members of the family of cyclin-dependent kinases (CDK) inhibitors (35), we decided to evaluate whether knockdown of six6b in zebrafish alters the expression of cdkn2b, another member of the CDK inhibitors previously associated in our GWAS studies with VCDR (16) and POAG (17) . RT-qPCR was performed at 3 dpf on injected and WT embryos, showing a 5.5-fold overexpression of cdkn2b in morphants compared with WT (P ¼ 1.56 × 10 202 ), while cdkn2c and cdkn2d (taken as a control) remain unaffected (Fig. 3C) . Expression levels of dacha and dachb at 3 dpf showed no differences between morphants and controls (data not shown).
Effect of six6b knockdown on cell proliferation in the developing eye of zebrafish
To evaluate whether up-regulation of cdkn2b in morphants leads to premature cell cycle exit, we examined the expression of the proliferating cell nuclear antigen (PCNA) in eye by immunostaining. WT embryos and morphants at 2, 3, 4 and 5 dpf were analyzed.
In WT fish at 2 dpf, almost all retinal progenitor cells showed a strong PCNA immunoreactivity (Fig. 4A) . As expected, in WT embryos at 3, 4 and 5 dpf, cells concentrated in the ciliary marginal zone were PCNA-positive (Fig. 4B -D) . The ciliary marginal zone is a proliferative zone described in eye of coldblooded vertebrates (47) . Thus, this finding is consistent with normal retinal differentiation processes in zebrafish (48, 49) . In contrast, morphants at 3 and 4 dpf showed numerous PCNA- 
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Human Molecular Genetics, 2014, Vol. 23, No. 5 positive cells in the photoreceptor and inner nuclear layers ( Fig. 4F and G) , suggesting that proliferation in morphants was not restricted to the ciliary marginal zone; on the contrary, retinas of morphants at 3 and 4 dpf showed a PCNA immunoreactivity pattern that resembled 2 dpf WT retinas. At 5 dpf morphants showed PCNA immunoreactivity mostly restricted to the ciliary marginal zone comparable with WT embryos (Fig. 4H) . We also investigated whether increased apoptosis was the cause of small eye phenotype. Caspase-3 staining did not show an increased apoptosis rate in morphants compared with WT embryos (Supplementary Material, Fig. S5 ).
DISCUSSION
In this study, we investigated the SIX1-SIX6 region in more detail to understand its role in optic nerve degeneration. Fine mapping and conditional analysis revealed a missense variant, rs33912345, in the SIX6 gene. Further analysis of the SIX6 exonic region revealed another rare missense variant, rs146737847. Both variants are located in the homeobox DNAbinding domain of SIX6 and are highly evolutionarily conserved. No common or rare variants in SIX1 were significantly associated to VCDR or POAG.
In line with previous findings, the rs33912345 has been described in patients with severe eye malformations, including anophthalmia, microphthalmia and coloboma (22, 50, 51) . It is in complete linkage disequilibrium with the reported SNP rs10483727, which is known to be associated with VCDR and POAG (16, 17, 30) . The rs146737847 variant has been reported in POAG cases of United States at the American Society of Human Genetics meeting 2012 (http://www.ashg.org/2012m eeting/abstracts/fulltext/f120122353.htm).
SIX6 in adult human tissues is highly expressed in the choroid, ciliary body, sclera, optic nerve head and retina, particularly GCL, INL and ONL (43) . Mouse, chick and Xenopus studies have demonstrated a role of Six6 during eye development (22, 26, 35, 52) , whereas Six1 is highly expressed in skeletal Figure 3 . six6, six3a/six3b and cdkn2b mRNA expression change. (A) WT relative expression of six6b, six3a and six3b over time from 1 to 5 dpf. Relative expression was calculated by setting the 1 dpf expression level at 1. Samples expression were normalized to the control gene b-actin (B) six6b knockdown in response to six6b SB-MO at 3 dpf. In addition, morphants showed downregulation of six3a but no six3b (C) Overexpression of cdkn2b in response to six6b depletion. All sample expression from experiments B and C were normalized to the control gene sdha. Relative expression was calculated by setting the WT expression level at 1. Values represent means + s.e.m.
* P , 0.05; * * P , 0.01.
Human 23) and plays a role in myogenesis (24) . Both our findings and the known biological function support the notion that SIX6, rather than SIX1, may play a role in VCDR and POAG.
To evaluate the function of the SIX6 gene on eye development and POAG. We used zebrafish as animal model due to its numerous advantages in comparison to mammalian models (53) . We assessed the effect of six6b knockdown in zebrafish. Deficiency of six6b in zebrafish led to a small eye phenotype, associated with small head and pericardial edema. Although morphants showed a small head, we found that the eye of morphants remains smaller independently of the head size. Other abnormalities, including diffused pigmentation were also observed. A clear connection between the visual system, particularly retinal-hypothalamic projections, and the control of pigment cells has been established (54) (55) (56) . In this study, six6b depleted embryos showed diffused pigmentation, a feature present in mutants who lack the ability to sense ambient light (57) . This may indicate an abnormal eye function in six6b morphants. Furthermore, histological sections of six6b morphants at 3 dpf showed a rudimentary lens, which indicates a developmental delay of the eye. Also, the optic nerve had a reduced thickness when compared with age-matched controls, which is relevant in the context of the neurodegenerative disease POAG. This finding is consistent with previous analysis of Six6 null mice (35) , which showed retinal hypoplasia, with often absence of optic nerve and chiasm. All these results support our hypothesis that the main effect of six6b knockdown is in the ocular system.
In flies, sine oculis (so) and Optix play a central role in eye development (25, 58) . In vertebrates, the Six3 and Six6 are the homologs of Optix. Both the Six3 and Six6 show high homology and are expressed during early stages of eye development (25, 26) . Six3 has a wide role in forebrain development, whereas Six6 has a more specific role in eye development (35, 45, 46, 52, (59) (60) (61) . We evaluated the effect of six6b knockdown on expression levels of six3a and six3b. No significant changes in expression levels of six3b were found in morphants compared with WT embryos. Interestingly, we found downregulation of six3a in six6b morphants. However, 14 mismatches between the six6b SB-MO and the six3a gene confirmed that our MO did not target six3a. Down-regulation of six3a in six6b morphants might suggest a complex feedback mechanism between six3a/six3b and six6b in zebrafish. Though both Six3 and Six6 might function through similar (62) and different (63) mechanisms, our results show that in zebrafish six6b is needed for normal eye development. Neither six3a nor six3b can compensate for six6b deficiency, resulting in a small eye phenotype.
Studies in medaka fish indicate that Six3 and the replicationinitiation inhibitor gemini act antagonistically to regulate the balance between proliferation and differentiation during eye development (62) . Six6 also interacts with gemini (62), supporting a potential role of Six6 in cell proliferation and differentiation. Additionally, in the Six6 null mice it was demonstrated that Six6 interacts with Dach1, a transcriptional co-repressor, to suppress Cdkn1b transcription in vivo (35) . Cdkn1b is a member of the CDK inhibitor family and controls the cell cycle progression, arresting cell proliferation. CDKN2B, a gene known to be associated with VCDR and POAG (16, 17, 27, 28, 30, 64) , is also a member of the CDK inhibitor family. CDKN2B controls G1 progression of the cell cycle and is highly induced by TGF-b (65), which in turn is one of the pathways involved in POAG pathogenesis (17) . We demonstrated a 5.5-fold overexpression of cdkn2b in six6b morphants compared with WT embryos. This finding is in accordance with a rat model of glaucoma (15) , in which overexpression of Cdkn2b was described after induction of high IOP. Up-regulation of cdkn2b arrests cell cycle progression causing an abnormal proliferation and small eye phenotype. 
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Based on our results, we conclude that Six6 repress the expression not only of Cdkn1b, as previously reported (35) , but also cdkn2b. This reveals a new interaction between the two known pathways associated with POAG (developmental and TGF-b signaling pathways) ( Fig. 5A ; www.ingenuity.com). Next, we evaluated the proliferative activity of retinal cells through PCNA assessment. PCNA allows detection of cells in either G1 or S phase of the cell cycle. We found that knockdown of six6b changes the pattern of positive PCNA labeling. Similar results were found in a previous study, in which a collagen gene (drCol15a1b) was knockdown in zebrafish (66) . It is well established that retinal progenitor cells start a differentiation process when they exit the cell cycle (66, 67) . Analysis of drCol15a1b morphants indicated that cells arrested in a proliferative state were undifferentiated (66) . Our results demonstrate an abnormal proliferation in the presence of an efficient knockdown of six6b with a recovery at 5 dpf. This could be explained by a reduced morpholino activity, as a consequence of its dilution due to cell growth and division. Based on our findings, we hypothesized that decreased expression of six6b may lead to fewer differentiated cells as depicted by our proposed model in Figure 5B . This needs to be assessed in future studies by evaluating the presence of retinal-differentiated cells in the eyes of six6b morphants. Caspase-3 assessment did not show an increased number of apoptotic cells in the eye of six6b-depleted embryos.
In conclusion, by combining fine-mapping and exome sequence analysis we found that SIX6, rather than SIX1, is responsible for the association signal previously reported in the SIX1/ SIX6 region. We found two variants located in the DNA-binding homeodomain of SIX6, which were significantly associated with VCDR. The rs33912345 variant was also associated with POAG in our study. Knockdown of six6b in zebrafish led to a small eye phenotype, as a result of an abnormal proliferative pattern in retinal cells. This alteration may also be associated with a disturbance in the differentiation process of retinal progenitor cells. Additionally, we were able to find an in vivo interaction between proteins identified by the GWAS (SIX6 and CDKN2B) for POAG. Further biological research is needed to verify the exact mechanism behind this interaction. Our findings from genetic association and functional studies demonstrate that SIX6 is a susceptibility gene for POAG and is involved in early eye development. This study provides new insight into the complex genetic architecture of POAG.
MATERIALS AND METHODS
Human and fine-mapping studies
Study populations
The RS is a prospective cohort study in the district Ommoord of Rotterdam. The rationale and study design are described elsewhere (68) . The original cohort (RS-I) consisted of 7983 residents aged ≥55 years. In 2000, the cohort was extended with 3011 residents aged ≥55 years (RS-II). In 2006, the cohort was further expanded with 3932 residents aged 45-54 years (RS-III). Details about examinations in each one of the cohorts are described elsewhere (16). The ERF Study is a family-based study in a genetically isolated population in the southwest of the Netherlands. It includes over 3000 participants with age varying between 18 and 86 years old. The cross-sectional examinations took place between 2002 and 2005. The rationale and study design have been described elsewhere (69, 70) .
An independent series of 104 glaucoma cases from an isolated population (the Genetic Research in an Isolated Population [GRIP] study) was used for a case -control analysis. These patients were recruited in three local hospitals in the geographical region of the ERF study. They did not participate in the ERF study. Participants from the ERF study were used as the control population.
Ophthalmic examinations
The ophthalmic assessment in the RS and ERF study included a medical history, autorefraction, keratometry, IOP measurements, visual field testing, fundus photography and optic nerve head imaging. Details about IOP and optic disc measurements are described elsewhere (16, 71) . In RS-I, glaucoma diagnosis was based on glaucomatous visual field loss (GVFL). The visual field of each eye was screened using a 52-point suprathreshold test that covered the central visual field with a radius of 248, and that tested the same locations as used in the Glaucoma Hemifield Test. Participants with a reproducible visual field loss in a second supra-threshold test, were evaluated with a Goldmann kinetic perimetry or full-threshold HFA test by a skilled perimetrist on both eyes. We incorporated prevalent glaucoma cases, (72) as well as incident cases (73) based on GVFL during at least one of the examination rounds. VCDR per se was not an inclusion criteria of the diagnosis. In GRIP/ERF, the diagnosis was based on the optic disc appearance, visual field testing and angle assessment.
The study protocols were approved by the Medical Ethics Committee of the Erasmus University, and all participants have given a written informed consent in accordance with the Declaration of Helsinki.
Genotyping and statistical analyses of fine-mapping studies Illumina Infinium II HumanHap550 chip v3.0 array was used for DNA genotyping in RS-I, RS-II and RS-III. In the ERF study, genotyping was performed using Illumina 318 K, Illumina 370 K, Illumina 610 K and Affymetrix 250 K genotyping platforms. Imputation for both studies was done by using 1000 Genomes Phase 1 (v3) as the reference.
We used the mean IOP, VCDR or ODA of both eyes. In cases of missing or unreliable data on one eye, the other eye was taken. Participants with a history of glaucoma laser or surgery were excluded for the IOP analysis. IOP measurements of participants with IOP lowering medication were imputed by adding 25% to the value of the measurement. We used 1000 Genomes Phase 1(v3) to perform fine mapping and modeling of SIX1/SIX6 locus in relation to these continuous outcomes on an assumed additive model for the effect of the risk allele. Additionally, we examined through logistic regression the association between the SIX1/SIX6 locus and primary open-angle glaucoma. All analyses were adjusted for age, sex, the first two principal components (RS) or family structure (ERF). Extra adjustments were done with spherical equivalent, as a measure of myopia, to evaluate whether the missense variant rs33912345 was independently associated with VCDR. The spherical equivalent was calculated for each eye using the standard formula: spherical equivalent ¼ sphere + 1/2 cylinder. Additionally, independence between rs10483727 and rs33912345 was tested, adjusting for the last one. Then, an inverse variance weighted metaanalysis was performed.
Exome sequencing
Exomes of 1309 individuals from the ERF population were sequenced 'in-house' at the Center for Biomics of the Cell Biology department of the Erasmus MC, The Netherlands, using the Aligent version V4 capture kit on an Illumina Hiseq2000 sequencer and the TrueSeq Version3 protocol. The sequences reads were aligned to the human genome build 19 (hg19) using Burrows-Wheeler Aligner (74) and NARWHAL pipeline (75) . For each sample, at least 4 Gigabases of sequence was aligned to the genome with an average fold-coverage of 74.23x per base. Subsequently, the aligned reads were processed further using the Indel Realigner, Mark Duplicates and Table Recalibration tools from the Genome Analysis Toolkit (GATK) (76) and Picard (http: picard.sourceforge.net) to remove systematic biases and to recalibrate the PHRED quality scores in the alignments. Genetic variants were called using the Unified Genotyper Tool from GATK. Of the 1309 individuals, 1208 had data on VCDR. As the ERF study included related individuals, association analysis was performed in SOLAR using procedure 'polygenic -screen', and adjusting for age and sex. In total, two variants in SIX1 and seven variants in SIX6 with a call rate of .0.99 were found. Only one of the nine variants at SIX6, rs146737847, reached significance levels. In addition, conditional analyses were performed with the rs33912345, previously found in the fine-mapping analysis.
eQTL and expression analyses
We used the Genotype-Tissue expression (GTex) project database (www.broadinstitute.org/gtex/) to examine whether rs10483727, rs33912345 or rs146737847 had a cis-or transeQTL effect. Although the GTex database does not include eye tissues, it contains more than 10 different brain regions and other tissues. For trans-eQTL analysis, a P-value of 5 × 10 213 was considered significant (38) . Additionally, we compared expression levels of SIX1 and SIX6 using the Ocular Tissue Database (https://genome.uiowa. edu/otdb/). The gene expression is indicated as Affymetrix Probe Logarithmic Intensity Error (PLIER) number. The PLIER numbers were calculated by GC-background correction, PLIER normalization, log transformation and z-score calculation (39) . Larger PLIER numbers represent high expression levels of a particular gene in particular tissue.
Statistical analysis of zebrafish experiments
Statistical analysis was performed using SPSS statistics 20. Analysis of E:B and E:H ratios was performed using the Student's t-test. Each group (six6b SB-MO injected, p53 MO injected and six6b SB-MO + p53 MO co-injected) was compared individually with the WT group (n ¼ 30, in each group). All RT-qPCR experiments were undertaken in triplicate. Results were considered statistically significant when P , 0.05, and are denoted in the figures with an asterisk.
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Zebrafish maintenance
The zebrafish (Danio rerio) strain used for this work was the Tupfel long fin (TL). Adults were maintained at 288C on a 14 hour-light/10 h dark cycle. Embryos were collected from natural mating and raised in system water containing methylene blue at 288C. Developmental stages were determined according to Kimmel (77) . All procedures and conditions were in accordance with the Dutch animal welfare legislation. The use of zebrafish for this study was approved by the Institutional Review Board for experimental animals of the Erasmus MC, Rotterdam.
Genetic analysis of the zebrafish SIX6 ortholog The zebrafish six6 ortholog was retrieved from Ensembl using the comparative genomics tool (78) . Two genes were found, six6a (ENSDARG00000025187) and six6b (ENSDARG00000031316).
In this study, we reported the effect of six6b knockdown. We sequenced WT zebrafish six6b to corroborate the reference sequence and select the regions for morpholino oligonucleotide (MO) design.
Morpholino and mRNA microinjections
Morpholino antisense oligonucleotides were obtained from Gene-Tools (Philomath, OR, USA). Two morpholinos were designed against six6b. One morpholino was designed to target the translation initiation site: AUG-MO ¼ 5 ′ -AAATTGG CAACTGAAACATGAAGGC-3 ′ ; and the second morpholino targeted exon 1 donor site: SB-MO ¼ 5
′ -TGTAAATCTGGAA AACGCACCTGTT-3
′ . All MO sequences were aligned with the Danio rerio genome using NCBI and UCSC Blast to confirm specificity to the six6b genomic region and ratify that neither the AUG-MO nor the SB-MO recognized six6a, six3a or six3b. A previously described MO designed to target the translation site of p53 (p53-MO ¼ 5
′ -GCGCCATTGCTTTGC AAGAATTG-3 ′ was used for control experiments (79) . Morpholinos were reconstituted in distilled water and further diluted in Danieau solution containing 0.1% Phenol Red for microinjections into embryos.
Indicated dosages of MOs were injected into the yolk of one to two cell stage using a pneumatic picopump (World Precision Instruments, Berlin, Germany). Optimum dose was considered when maximal knockdown efficiency, low mortality rate and small eye phenotype without severe malformations were observed on injected embryos. Six nanograms of either SB or AUG-MO were selected as optimal concentration. In separate experiments, 4 ng of p53-MO was co-injected with 6 ng of six6b-specific MO (SB or AUG), in order to detect off-target effects due to activation of p53 expression.
For MO rescue experiments, WT Danio rerio six6b cDNA was ligated into the pCR2.1-TOPO vector (Invitrogen), and subcloned at the site of EcoRI in pCS2+ vector. The fidelity of six6b-pCS2 was verified by direct sequencing. Using as template NsiI linearized six6b-pCS2, WT six6b mRNA was synthesized using a mMESSAGE mMACHINE SP6 kit (Ambion Inc). Double injection of mRNA and MO was carried out in two steps, first 3 ng six6b SB-MO were injected into the yolk, then a second injection with 9 pg six6b mRNA into the cell was performed, all embryos were injected in one-cell stage. Eye size was evaluated at 3 dpf.
RNA isolation and RT-qPCR
Pooled embryos were snap frozen in liquid nitrogen and stored at 2808C. Total RNA from 60 WT embryos at 1,2,3,4 and 5 dpf was isolated for time series analyses. For evaluation of six6b knockdown, total RNA was isolated from 60 morphants and WT embryos at 3 dpf; in all extractions an RNA-Bee (Tri-Test, Inc) protocol was used. Synthesis of cDNA was performed using Superscript III reverse transcriptase (Invitrogen, CA, USA). To measure mRNA levels, qRT-PCR on cDNA samples was carried out using an SYBR w select Master Mix for CFX (Applied Biosystems, Inc., USA). All samples were analyzed on the Bio-Rad CFX96 qPCR detection system.
Primers used for qRT-PCR were designed using Primer3Plus tool (80) . Primers for the reference genes sdha and b-actin were designed using Primer Express software (version 2.0.0). Oligonucleotide sequences are shown in detail in Supplementary Material, Table S1 .
Eye measurements WT and morphant embryos at 5 dpf were euthanized and fixed in 4% paraformaldehyde at 48C overnight. Photographs were made at a fixed magnification of the dorsal view of the whole embryo with a camera (Olympus DP72) attached to a dissecting microscope (Olympus SZX 16). The cellSense imaging software (Olympus) was used to measure eye, head and body length for each embryo. Eye length was defined as the longest dimension of the elliptical eye, head length was determined from the most anterior part of the head to the otic vesicles, as previously described (81) and body length was measured from the tip of the head to the end of the trunk. The ratio of the eye size to body length (E:B) was measured to determine the relative size of the eye (40) . The ratio of the eye size to head length (E:H) was measured to evaluate the effect of six6b depletion on eye size, independently of the head length.
For the assessment of the rescue experiments, three eye measurements from the dorsal view of embryos at 3 pdf were made. First, the eye length (defined previously) and called anteriorposterior length (AP), second the superior -inferior (SI) length defined as the longest dimension along the superior -inferior axis and third the total eye area. All measurements were traced using the Count & Measure function of the cellSense imaging software.
Histological analysis
Histological analysis was performed using standard protocols. Briefly, embryos were fixed in 4% paraformaldehyde at 48C overnight, embedded in paraffin using standard procedures and cut in 6 mm sections. Subsequently, histological hematoxylineosin staining of the sections was carried out using a standard protocol.
Immunohistochemistry
Briefly, deparaffinnized sections were pretreated for antigen retrieval by microwave heating in 0.1 m sodium citrate buffer (ph 6) for time series of 9-3-3 min. Expression pattern of six6 in larvae at 3 dpf was evaluated using a rabbit polyclonal antibody against six6 (1:400, Sigma). Proliferating cells were labeled using a mouse monoclonal antibody to PCNA (1:32000, Human Molecular Genetics, 2014, Vol. 23, No. 5 1329 Sigma). All antibody incubations were carried out overnight at 48C followed by incubation with a secondary antibody (BrightVision Poly-HRP-anti-rabbit IgG or poly-HRP-Anti-mouse, respectively) and indirect immunoperoxidase labeling and hematoxylin counter stain was performed.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online. 
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